Infleqtion executives to speak at Q+AI Conference in New York

Published 17/10/2025, 14:06
Infleqtion executives to speak at Q+AI Conference in New York

NEW YORK - Quantum technology company Infleqtion will participate in the 2025 Q+AI Conference taking place October 19-21 in New York City, according to a press release issued Friday.

The company, which specializes in neutral atom-based quantum technology, will have two executives speaking at the event. Chief Strategy Officer Paul Lipman will join a panel on applications for quantum AI in government, military, and intelligence services on October 20, while Chief Technology Officer Pranav Gokhale will speak on quantum approaches to designing AI software on October 21.

"Neutral-atom architectures are maturing quickly, and when paired with emerging AI techniques we’re seeing performance and programmability improvements that translate into measurable value," Gokhale said in the statement.

The Q+AI Conference brings together experts from quantum computing, artificial intelligence, government, and industry to discuss the intersection of quantum technologies and AI.

Infleqtion announced plans last month to go public through a merger with Churchill Capital Corp X (NASDAQ:CCCX), currently valued at $1.03 billion. The SPAC’s shares have surged 93% over the past six months, though InvestingPro analysis suggests the stock is currently overvalued. The company develops quantum computers, precision sensors, and quantum software for government and commercial clients, with a portfolio that includes quantum RF systems, quantum clocks, and inertial navigation solutions.

The Boulder, Colorado-based company’s participation in the conference comes as it reports accelerated momentum in technology development and strategic collaborations focused on scalable quantum solutions. Despite a recent 12% weekly decline, CCCX maintains an excellent Financial Health Score of 3.9 according to InvestingPro, which offers 8 additional key insights about the company’s performance and valuation.

In other recent news, Churchill Capital Corp X has been highlighted as a noteworthy investment opportunity by Citron Research. The research firm suggested that Churchill Capital Corp X is a compelling trade in the quantum technology sector. Citron Research has pointed out that Infleqtion, the quantum technology company set to merge with Churchill Capital Corp X, is significantly ahead of its competitor Rigetti Computing in the race for quantum advancements. The firm predicts that the stocks of Churchill Capital Corp X and Rigetti Computing will reach parity soon, with Churchill Capital Corp X expected to eventually command a premium. These developments have led to increased attention from investors. Additionally, the potential merger with Infleqtion positions Churchill Capital Corp X strategically in the quantum technology market. This merger is seen as a significant move, highlighting the company’s future potential in the sector.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.